hsa-miR-20a

ncRNA information

ncRNA name

hsa-miR-20a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Ovarian Cancer

Cancer site

Ovary

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

28789409

Description

MicroRNA-20a contributes to cisplatin-resistance.

Tissue resource

ovarian cancer cisplatin-resistant OVCAR3/DDP

ovarian cancer cell lines OVCAR3

Experiment

qRT-PCR,Western blot

Institute

Country

Continent

Institutes for Systems Genetics, West China Hospital
     Copyright @ 2022 ISG. All Rights Reserved.